Type 2 diabetes: The best diet to eat to improve blood sugar levels and protect the brain
TYPE 2 diabetes is caused by poor insulin production in the pancreas causing blood sugar levels to soar. Very high blood sugar levels over a long period of time can damage vital parts of the body such as eyes, nerves, kidneys and blood vessels. It may come as a surprise that it can also affect the brain - but there is a diet that can help protect the brain. (Source: Daily Express - Health)
Source: Daily Express - Health - June 18, 2019 Category: Consumer Health News Source Type: news

The truth about the healing powers of tumeric 
Curcumin may even improve the function of the insulin-producing cells in the pancreas, important for controlling blood sugar levels, as one early study, published in Diabetes Care in 2012, found. (Source: the Mail online | Health)
Source: the Mail online | Health - June 18, 2019 Category: Consumer Health News Source Type: news

The Most Effective Diet For Reducing The Worst Kind Of Fat
The study, known as the CENTRAL trial, demonstrated that a low-carb Mediterranean diet had a more significant effect on reducing fat around the liver (hepatic fat), heart and the pancreas, compared to low-fat diets with similar calorie counts, although the weight loss was similar. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 17, 2019 Category: Pharmaceuticals Authors: Robert Glatter, MD, Contributor Source Type: news

Type 2 diabetes: Eating this vegetable could lower blood sugar
TYPE 2 diabetes is a common condition that is caused by a poor insulin production in the pancreas leading to uncontrolled blood sugar levels. One popular ingredient could help lower blood sugar levels. Are you getting enough in your diet? (Source: Daily Express - Health)
Source: Daily Express - Health - June 16, 2019 Category: Consumer Health News Source Type: news

WVU researcher studies new treatment for pancreatic cancer
(West Virginia University) If the American Cancer Society's projections prove accurate, more people will die from pancreatic cancer than from breast, brain, ovarian or prostate cancer this year. WVU researcher Brian Boone was part of a team that studied a new combination of drugs to treat pancreatic cancer. In their meta-analysis, the drug combination -- FOLFIRINOX -- was associated with better surgical options and longer overall survival. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2019 Category: International Medicine & Public Health Source Type: news

Chinese medicine formula Wu-Mei-wan found to prevent Type 2 diabetes
(Natural News) In these two studies, researchers from Huazhong University of Science and Technology in China investigated the mechanisms underlying wu mei wan’s ability to protect pancreatic beta cells and reduce insulin resistance. The results of their studies were published in BMC Complementary and Alternative Medicine and Evidence-Based Complementary and Alternative Medicine, respectively. Wu mei wan (WMW) is... (Source: NaturalNews.com)
Source: NaturalNews.com - June 13, 2019 Category: Consumer Health News Source Type: news

Pancreatic cancer: Are you aware of the six main risks?
PANCREATIC cancer has the lowest survival rate of all common cancers in the UK, with five-year survival less than seven percent. It is not exactly clear what causes pancreatic cancer but there are six main risk factors. (Source: Daily Express - Health)
Source: Daily Express - Health - June 13, 2019 Category: Consumer Health News Source Type: news

Special fibroblasts help pancreatic cancer cells evade immune detection
(Cold Spring Harbor Laboratory) A subpopulation of fibroblasts called apCAFs can interact with the immune system to help pancreatic cancer cells avoid detection. Understanding how they work can be key in developing therapeutics for pancreatic ductal adenocarcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 13, 2019 Category: Cancer & Oncology Source Type: news

Type 2 diabetes: Do you sleep like this? The sleeping pattern that increases diabetes risk
TYPE 2 diabetes is a serious condition that involves the insulin made by the pancreas not working properly. Sleeping patterns could increase the risk of developing type 2 diabetes. Are you at risk? (Source: Daily Express - Health)
Source: Daily Express - Health - June 12, 2019 Category: Consumer Health News Source Type: news

Immunotherapy and diabetes: A game of hide and seek?
(Osaka University) Immune checkpoint inhibitors (ICIs) are emerging as an effective treatment for certain cancers, but in rare cases can cause autoimmune diseases. Researchers at Osaka University explored a unique case of a patient with cancer whose pancreas was removed, and who was diagnosed with type 1 diabetes (an autoimmune disease) after receiving ICIs. The researchers stained tissue samples from the pancreas, allowing them to better understand the link between checkpoint inhibitors and type 1 diabetes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2019 Category: Cancer & Oncology Source Type: news

Novel Neoadjuvant Approach May Boost Surgical Success in Pancreatic Cancer Novel Neoadjuvant Approach May Boost Surgical Success in Pancreatic Cancer
In the majority of studied patients with locally advanced pancreatic cancer, total neoadjuvant treatment with fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFIRINOX) along with losartan and chemoradiation allowed complete tumor removal, according to a single-arm phase 2 trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 10, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Using tumor biomarkers to tailor therapy in metastatic pancreatic cancer
(Mary Ann Liebert, Inc./Genetic Engineering News) A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2019 Category: International Medicine & Public Health Source Type: news

How not being able to flush my stools led to a cancer diagnosis
EXCLUSIVE: Chris Davey, 59, of Bristol, visited his GP about his change in stools and itchy skin. He was one of the very few to be diagnosed with pancreatic cancer early and receive surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2019 Category: Consumer Health News Source Type: news

Advances in pancreatic cancer treatment extending lives: Mayo Clinic Radio Health Minute
Pancreatic cancer is one of the deadliest forms of cancer, and such a diagnosis has long been considered a death sentence. In this Mayo Clinic Radio Health Minute we hear from Dr. Mark Truty, a Mayo Clinic cancer surgeon, who along with a team of surgeons and oncologists published a study which found that with [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 7, 2019 Category: Databases & Libraries Source Type: news

Meet Thrive: The New Kid on the Liquid Biopsy Block
There’s a new player in the liquid biopsy field. Thrive Earlier Detection Corp., announced late last month that it has launched and has raised $110 million in its Series A round. The financing is pretty sizeable. To put this in perspective, Cambridge, MA-based Thrive’s round is $10 million more than Grail’s series A round, which was raised in 2016. Liquid Biopsy companies are known for having above-average financings (In 2017, Redwood City, CA-based, Guardant Health pulled in $360 million in funding at one point ). Part of the reason for the huge funding rou...
Source: MDDI - June 6, 2019 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

Biomarker predicts which pancreatic cysts may become cancerous
(Washington University School of Medicine) A multicenter team led by investigators at Washington University School of Medicine in St. Louis has taken a big step toward identifying the cysts likely to become cancerous. Testing fluid from cysts for a biomarker -- an antibody called mAb Das-1 -- the researchers were able to identify pancreatic cysts likely to become cancerous with 95% accuracy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 5, 2019 Category: Cancer & Oncology Source Type: news

Could Myriad ’s New Study Results Be Game Changers For Cancer Patients?
The 2019 American Society of Clinical Oncology’s meeting might be in the books, but the impact of some of the data released at the conference are certain to have implications for cancer patients for years to come. Myriad Genetics presented data from several studies at ASCO that will no doubt have a long-lasting impact on cancer detection and treatment. The Salt Lake City, UT-based company spoke with MD+DI during ASCO about results from both colorectal cancer and breast cancer studies. Some of the most talked-about results came from the Phase III POLO Study, which looked at how well the BRACAnalysis CDx id...
Source: MDDI - June 4, 2019 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer
TUESDAY, June 4, 2019 -- Maintenance therapy with olaparib is associated with improved progression-free survival in metastatic pancreatic cancer patients with a germline BRCA1 and/or BRCA2 mutation (gBRCAm), according to a study presented at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2019 Category: Pharmaceuticals Source Type: news

Pancreatic injuries in abdominal trauma in US adults: analysis of the National Trauma Data Bank on management, outcomes, and predictors of mortality - Kuza CM, Hirji SA, Englum BR, Ganapathi AM, Speicher PJ, Scarborough JE.
BACKGROUND AND AIMS: Traumatic pancreatic injury is associated with high morbidity and mortality rates, and the management strategies associated with the best clinical outcomes are unknown. Our aims were to identify the incidence of traumatic pancreatic in... (Source: SafetyLit)
Source: SafetyLit - June 4, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Native Hawaiians at far greater risk for pancreatic cancer
(University of Southern California) Native Hawaiians are at highest risk for pancreatic cancer, according to a USC study that provides a surprising look at disparities surrounding the deadly disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 3, 2019 Category: Cancer & Oncology Source Type: news

POLO trial for advanced pancreatic cancer: a new standard of care
(University of Chicago Medical Center) Treatment with the drug olaparib significantly reduced the risk of disease progression or death from metastatic pancreatic cancer, according to findings from the recently completed, international, phase-III POLO (Pancreas cancer OLaparib Ongoing) trial. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 3, 2019 Category: Cancer & Oncology Source Type: news

First Phase III Trial Validates Biomarker-Selected Therapy for Pancreatic Cancer
Data presented at ASCO 2019 suggest that a PARP inhibitor yields a clinically meaningful improvement in PFS in  metastatic pancreatic cancer patients with a germline BRCA mutation. (Source: CancerNetwork)
Source: CancerNetwork - June 3, 2019 Category: Cancer & Oncology Authors: Lauren M. Dembeck Source Type: news

Olaparib Delays Progression in BRCA-Mutated Pancreatic Cancer Olaparib Delays Progression in BRCA-Mutated Pancreatic Cancer
"It is our duty to search for this genetic mutation in all patients with metastatic pancreatic cancer so we can identify those people who can benefit," says Suzanne Cole, UT Southwestern Medical Center.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 2, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Olaparib Delays Progression in BRCA Pancreatic Cancer Olaparib Delays Progression in BRCA Pancreatic Cancer
"It is our duty to search for this genetic mutation in all patients with metastatic pancreatic cancer so we can identify those people who can benefit," says Suzanne Cole, UT Southwestern Medical Center.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 2, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation
When most people hear about BRCA genes, they immediately think about how inherited mutations in those genes -- BRCA1 and BRCA2 -- have been linked with higher risk of breast and ovarian cancer. (Source: CNN.com - Health)
Source: CNN.com - Health - June 2, 2019 Category: Consumer Health News Source Type: news

Lynparza stalls pancreatic cancer in patients with BRCA mutations: study
AstraZeneca and Merck& Co's Lynparza helped patients with advanced pancreatic cancer who carry BRCA gene mutations go nearly twice as long without their disease worsening than those who received a placebo, according to data from a late-stage clinical trial presented on Sunday. (Source: Reuters: Health)
Source: Reuters: Health - June 2, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Visceral fat: Three best ways to get rid of visceral fat
VISCERAL FAT is difficult to identify as its stored around the internal organs in the abdominal region which includes the liver, pancreas and intestines. What are two of the best ways to lower your visceral rating? (Source: Daily Express - Health)
Source: Daily Express - Health - June 1, 2019 Category: Consumer Health News Source Type: news

Grail Presents Early Favorable CCGA Data at ASCO
Grail has been firing on all cylinders ever since it was spun-out from Illumina three years ago. From massive clinical trials to outrageous financing amounts, the liquid biopsy specialist has not let up on meeting milestones. The latest milestone from the Menlo Park, CA-based company is fairly positive data from the Circulating Cell-free Genome Atlas (CCGA) study. The massive study is a prospective, observational, longitudinal trial that has completed enrollment of about 15,000 people with and without cancer across 142 sites in the U.S. and Canada. Grail presented the results during the 2019 American Society of Clinical On...
Source: MDDI - May 31, 2019 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

Misconception That Pancreatic Cancer'Not Worth Treating'Misconception That Pancreatic Cancer'Not Worth Treating '
A Canadian study shows that one third of patients were not referred to oncology service and that 64% did not receive treatment to prolong survival or reduce symptom burden.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 31, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Merrimack axes remaining staff, execs after selling assets to New York startup
After three years of clinical and business turmoil, Merrimack Pharmaceuticals is largely closing up shop and laying off the rest of its employees. Merrimack (Nasdaq: MACK), founded in 2000, has been developing treatments for breast, pancreatic and ovarian cancers. The company has shelved multiple drug candidates over the last three years due to safety issues and disappointing response rates. Merrimack stopped bringing in sales revenue in 201 7, after selling its sole commercial drugs to French drugmaker… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 31, 2019 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

A New Way to Fight a Previously 'Inoperable' Pancreatic Cancer
Title: A New Way to Fight a Previously 'Inoperable' Pancreatic CancerCategory: Health NewsCreated: 5/30/2019 12:00:00 AMLast Editorial Review: 5/31/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 31, 2019 Category: Cancer & Oncology Source Type: news

A New Way to Fight a Previously 'Inoperable' Pancreatic Cancer
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - May 31, 2019 Category: Cancer & Oncology Source Type: news

A New Way to Fight a Previously 'Inoperable' Pancreatic Cancer
(Source: Cancercompass News: Pancreatic Cancer)
Source: Cancercompass News: Pancreatic Cancer - May 31, 2019 Category: Cancer & Oncology Source Type: news

Trial: Gains Seen on Inoperable Pancreatic Cancer
In the clinical trial, 49 patients with locally advanced pancreatic cancer received intensive chemotherapy and radiation therapy, as well as the blood pressure drug losartan. (Source: WebMD Health)
Source: WebMD Health - May 31, 2019 Category: Consumer Health News Source Type: news

A New Way to Fight a Previously'Inoperable' Pancreatic Cancer
THURSDAY, May 30, 2019 -- A new treatment protocol for locally advanced pancreatic cancer can enable surgical removal of previously inoperable tumors and improve survival rates, according to a new study. " Locally advanced " pancreatic cancer is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 30, 2019 Category: General Medicine Source Type: news

Alex Trebek Says His Pancreatic Cancer Is 'Near Remission'
Title: Alex Trebek Says His Pancreatic Cancer Is 'Near Remission'Category: Health NewsCreated: 5/29/2019 12:00:00 AMLast Editorial Review: 5/30/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 30, 2019 Category: Cancer & Oncology Source Type: news

Interaction with stromal cells influences tumor growth, metastasis in pancreatic cancer
(Massachusetts General Hospital) A study from researchers at the Massachusetts General Hospital Cancer Center has demonstrated how the response to pancreatic cancer cells of normal tissue -- called the stroma -- within tumors can influence the ability of individual cancer cells to proliferate and metastasize (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 30, 2019 Category: Cancer & Oncology Source Type: news

Novel protocol significantly improves outcomes in locally advanced pancreatic cancer
(Massachusetts General Hospital) A Massachusetts General Hospital Cancer Center clinical trial of a protocol combining intensive chemotherapy and radiation therapy with the blood pressure drug losartan has produced unprecedented results in patients with locally advanced pancreatic cancer, allowing complete removal of the tumor in 61% of participants and significantly improving survival rates. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 30, 2019 Category: Cancer & Oncology Source Type: news

Stand up to cancer-funded research to be presented at ASCO May 31-June 4 in Chicago
(Stand Up To Cancer) SU2C supported researchers will present work on pediatric brain tumors, cfDNA for early cancer detection, dual blockade of CTLA-4 and PD-1 in mCRC, cancer interception of pancreatic and lung cancers, machine learning RECIST in RWE study of lung cancer, and molecular markers of response to neoadjuvant nivolumab in resectable NSCLC. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 30, 2019 Category: International Medicine & Public Health Source Type: news

Alex Trebek Says His Pancreatic Cancer Is 'Near Remission'
(Source: Cancercompass News: Pancreatic Cancer)
Source: Cancercompass News: Pancreatic Cancer - May 30, 2019 Category: Cancer & Oncology Source Type: news

Alex Trebek Says His Pancreatic Cancer Is ‘ Near Remission ’
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 29, 2019 Category: Cancer & Oncology Tags: Oncology, News, Source Type: news

Alex Trebek shares "mind-boggling" update on his pancreatic cancer
"The doctors said they hadn't seen this kind of positive result in their memory," Trebek says (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 29, 2019 Category: Consumer Health News Source Type: news

Alex Trebek Says His Pancreatic Cancer Is'Near Remission '
WEDNESDAY, May 29, 2019 -- Long-time " Jeopardy! " Host Alex Trebek may be winning his battle against pancreatic cancer, he and his doctors report. Trebek, 78, is responding incredibly well to treatments and is in " near remission, " his doctors said... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 29, 2019 Category: General Medicine Source Type: news

Blood Test Could Spot Multiple Cancer Types, Researchers Say
WEDNESDAY, May 29, 2019 -- A gene-based blood test can accurately detect breast, colorectal, lung, ovarian, pancreatic, gastric or bile duct cancers in patients, researchers report. The test uses artificial intelligence to identify and interpret... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 29, 2019 Category: General Medicine Source Type: news

Human Pancreatic CAFS and Tumor Dynamics
 Extracellular Matrix (ECM) MattersOurHuman Pancreatic Cancer Fibroblasts were recently featured in a publication focusing on the role of the ECM on tumor dynamics. Andreas Stylianou, Vasiliki Gkretsi, Maria Louca, Lefteris C. Zacharia, and Triantafyllos Stylianopoulos (2019).Collagen content and extracellular matrix cause cytoskeletal remodelling in pancreatic fibroblasts. J. R. Soc. Interface 16: 20190226. http://dx.doi.org/10.1098/rsif.2019.0226.Commercially available pancreatic native human FBs and,CAFs (cat. nos. SC00A5 and CAF08, respectively, Neuromics) were cultured in MSC-GRO (VitroPlus III, low serum, comple...
Source: Neuromics - May 29, 2019 Category: Neuroscience Tags: 3D collagen scaffolds Human Pancreatic Fibroblasts Pancreatic CAF-Stellate Cells pancreatic cancer Source Type: news

Alex Trebek shares 'mind-boggling' pancreatic cancer update
"Jeopardy!" host Alex Trebek says his doctors say he's in "near remission" of advanced pancreatic cancer and his response to the treatment is "kind of mind-boggling." (Source: ABC News: Health)
Source: ABC News: Health - May 29, 2019 Category: Consumer Health News Tags: Health Source Type: news

Surgery for Small Pancreatic Duct Dilatation to Prevent Cancer Surgery for Small Pancreatic Duct Dilatation to Prevent Cancer
' If we continue using the more conservative cutoff point … we will miss a lot of people who will go on to develop cancer,'says study author Ross Beckman, MD.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 29, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

AngioDynamics Sets Sights on Prostate Cancer with New IDE
FDA has given approval for AngioDynamics to undergo a pilot study of the NanoKnife for the ablation of prostate cancer tissue in low-risk patients. The IDE comes on the heels of the Latham, NY-based company making significant strides in its mission to obtain an indication for the treatment of pancreatic cancer. “NanoKnife has been in the market for a general soft tissue claim for about eight or nine years,” Brent Boucher, AngioDynamics, Senior VP and General Manager of Oncology, told MD+DI. “On April 1 we received approval to pursue a pancreas indication for stage three...
Source: MDDI - May 28, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Cancer Consultation Low in Noncurable Pancreatic Adenocarcinoma
Likelihood of cancer - directed therapy higher for first consult with medical, radiation oncology versus surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 28, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Radiology, Surgery, Journal, Source Type: news

Cancer Consultation Low in Noncurable Pancreatic Adenocarcinoma
TUESDAY, May 28, 2019 -- Many patients with noncurable pancreatic adenocarcinoma do not have a specialized cancer consultation and most do not receive cancer-directed therapy, according to a study published online May 27 in CMAJ, the journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 28, 2019 Category: Pharmaceuticals Source Type: news